Literature DB >> 35412246

Crystallization of Nuclear Export Signals or Small-Molecule Inhibitors Bound to Nuclear Exporter CRM1.

Ho Yee Joyce Fung1, Yuh Min Chook2.   

Abstract

The Karyopherin protein CRM1 or XPO1 is the major nuclear export receptor that regulates nuclear exit of thousands of macromolecules in the cell. CRM1 recognizes protein cargoes by binding to their 8-15 residue-long nuclear export signals (NESs). A ternary CRM1-Ran-RanBP1 complex engineered to be suitable for crystallization has enabled structure determination by X-ray crystallography of CRM1 bound to many NES peptides and small-molecule inhibitors. Here, we present a protocol for the purification of the individual proteins, formation of the ternary CRM1-Ran-RanBP1 complex and crystallization of this complex for X-ray crystallography.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CRM1; KPT; LMB; Leptomycin B; NES; Nuclear export signals; SINE; X-ray crystallography; XPO1

Mesh:

Substances:

Year:  2022        PMID: 35412246     DOI: 10.1007/978-1-0716-2337-4_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  An allosteric mechanism to displace nuclear export cargo from CRM1 and RanGTP by RanBP1.

Authors:  Masako Koyama; Yoshiyuki Matsuura
Journal:  EMBO J       Date:  2010-05-18       Impact factor: 11.598

2.  Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1.

Authors:  Qingxiang Sun; Yazmin P Carrasco; Youcai Hu; Xiaofeng Guo; Hamid Mirzaei; John Macmillan; Yuh Min Chook
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

3.  Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia.

Authors:  Rosa Lapalombella; Qingxiang Sun; Katie Williams; Larissa Tangeman; Shruti Jha; Yiming Zhong; Virginia Goettl; Emilia Mahoney; Caroline Berglund; Sneha Gupta; Alicia Farmer; Rajeswaran Mani; Amy J Johnson; David Lucas; Xiaokui Mo; Dirk Daelemans; Vincent Sandanayaka; Sharon Shechter; Dilara McCauley; Sharon Shacham; Michael Kauffman; Yuh Min Chook; John C Byrd
Journal:  Blood       Date:  2012-10-03       Impact factor: 22.113

4.  Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.

Authors:  Jeffery D Haines; Olivier Herbin; Belén de la Hera; Oscar G Vidaurre; Gregory A Moy; Qingxiang Sun; Ho Yee Joyce Fung; Stefanie Albrecht; Konstantina Alexandropoulos; Dilara McCauley; Yuh Min Chook; Tanja Kuhlmann; Grahame J Kidd; Sharon Shacham; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2015-02-23       Impact factor: 24.884

5.  Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies.

Authors:  Z A Hing; H Y J Fung; P Ranganathan; S Mitchell; D El-Gamal; J A Woyach; K Williams; V M Goettl; J Smith; X Yu; X Meng; Q Sun; T Cagatay; A M Lehman; D M Lucas; E Baloglu; S Shacham; M G Kauffman; J C Byrd; Y M Chook; R Garzon; R Lapalombella
Journal:  Leukemia       Date:  2016-05-20       Impact factor: 11.528

6.  Nuclear export receptor CRM1 recognizes diverse conformations in nuclear export signals.

Authors:  Ho Yee Joyce Fung; Szu-Chin Fu; Yuh Min Chook
Journal:  Elife       Date:  2017-03-10       Impact factor: 8.140

7.  Recognition of nuclear export signals by CRM1 carrying the oncogenic E571K mutation.

Authors:  Jordan M Baumhardt; Janek S Walker; Yoonji Lee; Binita Shakya; Chad A Brautigam; Rosa Lapalombella; Nick Grishin; Yuh Min Chook
Journal:  Mol Biol Cell       Date:  2020-06-10       Impact factor: 4.138

8.  Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells.

Authors:  J Etchin; Q Sun; A Kentsis; A Farmer; Z C Zhang; T Sanda; M R Mansour; C Barcelo; D McCauley; M Kauffman; S Shacham; A L Christie; A L Kung; S J Rodig; Y M Chook; A T Look
Journal:  Leukemia       Date:  2012-07-31       Impact factor: 11.528

9.  A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

Authors:  Koray Kırlı; Samir Karaca; Heinz Jürgen Dehne; Matthias Samwer; Kuan Ting Pan; Christof Lenz; Henning Urlaub; Dirk Görlich
Journal:  Elife       Date:  2015-12-17       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.